Share

May 19, 2015; 84 (20) Article

Occupational attainment influences survival in autopsy-confirmed frontotemporal degeneration

Lauren Massimo, Jarcy Zee, Sharon X. Xie, Corey T. McMillan, Katya Rascovsky, David J. Irwin, Ann Kolanowski, Murray Grossman
First published April 22, 2015, DOI: https://doi.org/10.1212/WNL.0000000000001595
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
181

Share

Article Information

vol. 84 no. 20 2070-2075
DOI: 
https://doi.org/10.1212/WNL.0000000000001595
PubMed: 
25904687
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received November 12, 2014
  • Accepted in final form February 11, 2015
  • First Published April 22, 2015.

Article Versions

Copyright & Usage: 
© 2015 American Academy of Neurology

Author Disclosures

    1. Lauren Massimo, PhD, CRNP,
    2. Jarcy Zee, PhD,
    3. Sharon X. Xie, PhD,
    4. Corey T. McMillan, PhD,
    5. Katya Rascovsky, PhD,
    6. David J. Irwin, MD,
    7. Ann Kolanowski, PhD, RN and
    8. Murray Grossman, MD, EdD
  1. Lauren Massimo, PhD, CRNP,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1)NIH/NINR, F32NR014777 (2014-current), F31NR013306 (2011-2014), Principal investigator

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Jarcy Zee, PhD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Unrealated to manuscript: Funding source: NIH grant #T32MH065210. Role: Pre-doctoral trainee.

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Sharon X. Xie, PhD,
    4. Scientific Advisory Boards:

    1. Dr. Xie served as a consultant to Roche on a clinical trial unrelated to this study.

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Alzheimer's & Dementia, Associate Editor, 2013-present

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Dr. Xie is currently funded by NIH grants P30-AG010124, P50-NS053488,P01-AG032953, P01-AG017586, R01-AG040271, and U01-NS082134.

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Corey T. McMillan, PhD,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. (2) Payment of $1000 CAD for being plenary speaker at the 2015 International Conference on Frontotemporal Degeneration.

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH Loan Repayment Program NIH AG043503

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Katya Rascovsky, PhD,
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. This work was supported by NIH grants AG17586, AG32953, AG046499 and NS44266

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. David J. Irwin, MD,
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH/NIA T32-AG000255 Research Fellow/Trainee 2010, NIH/NIA P30 AG010124-20 Research Fellow/Trainee 2010 NIH/NINDS 1K23NS088341-01

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. Ann Kolanowski, PhD, RN and
    8. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) National Institutes of Health/National Institute of Nursing Research, R01 NR012242,Principal Investigator, 2010-2015 (2) National Institutes of Health/National Institute of Nursing Research, R01 NR011042, Co-Investigator, 2010-2015 (3) National Institutes of Health/National Institute of Nursing Research, R01 NR012737, consultant, 2011-2015

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. John A. Hartford Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  8. Murray Grossman, MD, EdD
    9. Scientific Advisory Boards:

    1. Forum

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Max-Planck Society, travel to a site visit

    Editorial Boards:

    1. Neurology, Editorial Advisory Board Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, Editorial Board Journal of Neurolinguistics, Editorial Board Journal of Alzheimer's Disease, Editorial Board

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Research support from NIH (PI of grant or project, or CL of core): AG17586, NS44266, NS53488, AG32953, AG38490

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Wyncote Foundation ALS Association

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Frontotemporal Degeneration Center, Department of Neurology (L.M., C.T.M., K.R., D.J.I., M.G.), and Department of Biostatistics and Epidemiology (J.Z., S.X.X.), Perelman School of Medicine, University of Pennsylvania, Philadelphia; and The Pennsylvania State University (L.M., A.K.), College of Nursing, University Park, PA.
  1. Correspondence to Dr. Massimo: massimol{at}uphs.upenn.edu
View Full Text

Article usage

Article usage: April 2015 to July 2022

AbstractFullPdfSource
Apr 2015801014Highwire
May 201513841646Highwire
Jun 2015350515Highwire
Jul 201517653Highwire
Aug 201515246Highwire
Sep 201516102Highwire
Oct 201510621Highwire
Nov 201510414Highwire
Dec 201511300Highwire
Jan 20166000Highwire
Feb 20166210Highwire
Mar 20164300Highwire
Apr 20163611Highwire
May 20165510Highwire
May 2016061pmc
Jun 20166911Highwire
Jun 2016071pmc
Jul 20164700Highwire
Jul 2016032pmc
Aug 20166600Highwire
Aug 2016031pmc
Sep 20163701Highwire
Sep 2016011pmc
Oct 20166201Highwire
Oct 2016053pmc
Nov 20164500Highwire
Nov 2016041pmc
Dec 20164201Highwire
Dec 2016071pmc
Jan 20173900Highwire
Jan 20170112pmc
Feb 20173600Highwire
Feb 2017021pmc
Mar 20174012Highwire
Mar 2017040pmc
Apr 20173200Highwire
Apr 2017144pmc
May 20172310Highwire
May 2017375pmc
Jun 20172000Highwire
Jun 2017133pmc
Jul 20171900Highwire
Jul 2017011pmc
Aug 20171601Highwire
Aug 2017144pmc
Sep 20171711Highwire
Sep 2017268pmc
Oct 20172500Highwire
Oct 2017265pmc
Nov 20172200Highwire
Nov 201711516pmc
Dec 20173511Highwire
Jan 20181701Highwire
Feb 20183540Highwire
Mar 20185220Highwire
Apr 20184400Highwire
Apr 2018033pmc
May 20184500Highwire
Jun 20186500Highwire
Jun 2018144pmc
Jul 20184100Highwire
Aug 20183400Highwire
Aug 2018110pmc
Sep 20182300Highwire
Oct 20183111Highwire
Nov 20186100Highwire
Dec 20184800Highwire
Jan 20193100Highwire
Feb 20192500Highwire
Mar 20191300Highwire
Apr 20193012Highwire
May 20193100Highwire
Jun 20191000Highwire
Jul 20191200Highwire
Aug 20191611Highwire
Sep 20191700Highwire
Oct 20191700Highwire
Nov 20192600Highwire
Dec 20191300Highwire
Jan 20201600Highwire
Feb 20203000Highwire
Mar 20201100Highwire
Apr 20201010Highwire
May 20201100Highwire
Jun 2020611Highwire
Jul 20201301Highwire
Aug 2020600Highwire
Sep 20201610Highwire
Oct 20201400Highwire
Nov 20202010Highwire
Dec 20201600Highwire
Jan 2021710Highwire
Feb 20211311Highwire
Mar 2021900Highwire
Apr 20212300Highwire
May 20212611Highwire
Jun 20211700Highwire
Jul 20212610Highwire
Aug 20211810Highwire
Sep 20211301Highwire
Oct 20212200Highwire
Nov 20212000Highwire
Dec 20212500Highwire
Jan 2022900Highwire
Feb 20221900Highwire
Mar 20221621Highwire
Apr 20222940Highwire
May 20221901Highwire
Jun 20221300Highwire
Jul 20222001Highwire

Cited By...

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me